Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients With Vasculogenic Erectile Dysfunction: A Triplex Ultrasonography-Based Sham-Controlled Trial

被引:64
作者
Kalyvianakis, Dimitrios [1 ]
Hatzichristou, Dimitrios [1 ]
机构
[1] Aristotle Univ Thessaloniki Greece, Ctr Sexual & Reprod Hlth, Thessaloniki, Greece
关键词
Low-Intensity Shockwave Therapy; Erectile Dysfunction; Peak Systolic Velocity; Penile Doppler; WAVE THERAPY; DOUBLE-BLIND; CELLS;
D O I
10.1016/j.jsxm.2017.05.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Although several reports have documented the subjective improvement of erectile function after low-intensity extracorporeal shockwave therapy (LI-ESWT) in patients with vasculogenic erectile dysfunction (ED), objective assessment data of penile hemodynamics are lacking. Aim: To assess penile hemodynamics before and 3 months after LI-ESWT in a group of patients with documented vasculogenic ED. Methods: This was a double-blinded, randomized, sham-controlled trial. Forty-six patients with ED were randomized; 30 underwent LI-ESWT and 16 had a sham procedure in double-blinded fashion. All patients underwent penile triplex ultrasonography by the same investigator immediately before and 3 months after treatment. Patient demographics, International Index of Erectile Function erectile function domain (IIEF-ED) score, and minimal clinically important difference were assessed at baseline and 1, 3, 6, 9, and 12 months after treatment. Outcomes: Changes in peak systolic velocity and resistance index as measured by triplex ultrasonography at baseline and 3 months after treatment were the main outcomes of the study. Secondary outcomes were changes in the IIEF-EF score from baseline to 1, 3, 6, 9, and 12 months after treatment and the percentage of patients reaching a minimal clinically important difference during the same period for the two groups. Results: IIEF-EF minimal clinically important differences for the active vs sham group were observed for 56.7% vs 12.5% (P=.005) at 1 month, 56.7% vs 12.5% (P=.003) at 3 months, 63.3% vs 18.8% (P=.006) at 6 months, 66.7% vs 31.3% (P=.022) at 9 months, and 75% vs 25% (P=.008) at 12 months. Mean peak systolic velocity increased by 4.5 and 0.6 cm/s in the LI-ESWT and sham groups, respectively (P<.001). Clinical Implications: Such results offer objective and subjective documentation of the value of this novel treatment modality for men with vasculogenic ED. Strengths and Limitations: Strengths include the prospective, randomized, sham-controlled type of study and the assessment of penile hemodynamics. Limitations include the small sample and strict inclusion criteria that do not reflect everyday clinical practice. Conclusion: The present study confirms the beneficial effect of LI-ESWT on penile hemodynamics and the beneficial effect of this treatment up to 12 months. Copyright (C) 2017, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:891 / 897
页数:7
相关论文
共 24 条
[1]  
[Anonymous], 2017, EUR UROL, V71, pe59
[2]   Extracorporal Shock Waves Activate Migration, Proliferation and Inflammatory Pathways in Fibroblasts and Keratinocytes, and Improve Wound Healing in an Open-Label, Single-Arm Study in Patients with Therapy-Refractory Chronic Leg Ulcers [J].
Aschermann, Ilknur ;
Noor, Seema ;
Venturelli, Sascha ;
Sinnberg, Tobias ;
Mnich, Christian D. ;
Busch, Christian .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (03) :890-906
[3]   Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis [J].
Clavijo, Raul I. ;
Kohn, Taylor P. ;
Kohn, Jaden R. ;
Ramasamy, Ranjith .
JOURNAL OF SEXUAL MEDICINE, 2017, 14 (01) :27-35
[4]   Shockwave treatment of erectile dysfunction [J].
Gruenwald, Ilan ;
Appel, Boaz ;
Kitrey, Noam D. ;
Vardi, Yoram .
THERAPEUTIC ADVANCES IN UROLOGY, 2013, 5 (02) :95-99
[5]   Low-Intensity Extracorporeal Shock Waves Therapy (LI-ESWT) for the treatment of erectile dysfunction: Where do we stand? [J].
Hatzichristou, Dimitris .
EUROPEAN UROLOGY, 2017, 71 (02) :234-236
[6]   Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015) [J].
Hatzimouratidis, Konstantinos ;
Salonia, Andrea ;
Adaikan, Ganesan ;
Buvat, Jacques ;
Carrier, Serge ;
El-Meliegy, Amr ;
McCullough, Andrew ;
Torres, Luiz Otavio ;
Khera, Mohit .
JOURNAL OF SEXUAL MEDICINE, 2016, 13 (04) :465-488
[7]   Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation [J].
Hatzimouratidis, Konstantinos ;
Amar, Edouard ;
Eardley, Ian ;
Giuliano, Francois ;
Hatzichristou, Dimitrios ;
Montorsi, Francesco ;
Vardi, Yoram ;
Wespes, Eric .
EUROPEAN UROLOGY, 2010, 57 (05) :804-814
[8]   Extracorporeal Shock Wave Therapy for Ischemic Cardiovascular Disorders [J].
Ito, Kenta ;
Fukumoto, Yoshihiro ;
Shimokawa, Hiroaki .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2011, 11 (05) :295-302
[9]   Double-Blind and Placebo-Controlled Study of the Effectiveness and Safety of Extracorporeal Cardiac Shock Wave Therapy for Severe Angina Pectoris [J].
Kikuchi, Yoku ;
Ito, Kenta ;
Ito, Yoshitaka ;
Shiroto, Takashi ;
Tsuburaya, Ryuji ;
Aizawa, Kentaro ;
Hao, Kiyotaka ;
Fukumoto, Yoshihiro ;
Takahashi, Jun ;
Takeda, Morihiko ;
Nakayama, Masaharu ;
Yasuda, Satoshi ;
Kuriyama, Shinichi ;
Tsuji, Ichiro ;
Shimokawa, Hiroaki .
CIRCULATION JOURNAL, 2010, 74 (03) :589-591
[10]  
Lei H, 2015, UROLOGY, V86, P1241